CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

The year in cardiology: heart failure: The year in cardiology 2019 Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure The spectrum of heart failure: value of left ventricular ejection fraction and its moving trajectories Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

Clinical Trial2014 Sep 11;371(11):993-1004.

JOURNAL:N Engl J Med. Article Link

Angiotensin–neprilysin inhibition versus enalapril in heart failure

McMurray JJ, Packer M, PARADIGM-HF Investigators and Committees. Keywords: angiotensin receptor-neprilysin inhibitor LCZ696; enalapril; HFrEF; mortality; survival; hospitalization for heart failure

FULL TEXT PDF